- Products
- Catalogs
- News & Trends
- Exhibitions
COVID-19 rapid test Gmate®for antigensnasopharyngealimmunochromatographic
Add to favorites
Compare this product
Characteristics
- Applications
- COVID-19
- Tested parameter
- for antigens
- Sample type
- nasopharyngeal
- Analysis mode
- immunochromatographic
- Result display time
15 min
- Specificity
98.5 %
- Sensitivity
91.1 %
Description
Gmate COVID-19 Ag kit is an in vitro diagnostic medical device that qualitatively detects antigens against COVID-19 in the nasopharyngeal smear of patients by immunochromatography.
Note
KMFDS Certified, CE-IVD Certified
Handy Use without the Analyzer
Various Variants Detectable
Performance
Overall Accuracy : 96.67%
Packaging
Bulk Package : 25 Tests / Box
Single Package : 1 Test / Box
Related Searches
- Blood rapid diagnostic test
- Rapid lateral flow test
- Immunoassay rapid diagnostic test
- Rapid virus test
- Serum rapid diagnostic test
- Plasma rapid diagnostic test
- Whole blood rapid diagnostic test
- Rapid respiratory infection test
- COVID-19 rapid diagnostic test
- POC reader
- Nasopharyngeal rapid diagnostic test
- Rapid oral flu test
- POC reader with touchscreen
- Optical POC analyzer
- Cell rapid diagnostic test
- Antigen POC reader
- Respiratory disease POC analyzer
- Immunity rapid diagnostic test
- POC virus analyzer
- Neutralizing antibody rapid test
*Prices are pre-tax. They exclude delivery charges and customs duties and do not include additional charges for installation or activation options. Prices are indicative only and may vary by country, with changes to the cost of raw materials and exchange rates.